Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in AIDS

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    October 2017
  1. LACOURSE SM, Pavlinac PB, Cranmer LM, Njuguna IN, et al
    Stool Xpert MTB/RIF and urine lipoarabinomannan (LAM) for diagnosing tuberculosis in hospitalized HIV-infected children.
    AIDS. 2017 Oct 12. doi: 10.1097/QAD.0000000000001662.
    PubMed     Text format     Abstract available


    August 2017
  2. WINTER JR, Stagg HR, Smith CJ, Brown AE, et al
    Injecting drug use predicts active tuberculosis in a national cohort of people living with HIV from 2000 to 2014.
    AIDS. 2017 Aug 28. doi: 10.1097/QAD.0000000000001635.
    PubMed     Text format     Abstract available


    June 2017
  3. LECCA L, Galea J, Contreras CC, Millones AK, et al
    Challenges in tuberculosis/HIV management in a country with a concentrated HIV epidemic.
    AIDS. 2017;31:1207-1209.
    PubMed     Text format    


    January 2017

  4. One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.
    AIDS. 2017;31:375-384.
    PubMed     Text format     Abstract available


    November 2016
  5. KUNKEL A, Crawford FW, Shepherd J, Cohen T, et al
    Benefits of continuous isoniazid preventive therapy may outweigh resistance risks in a declining tuberculosis/HIV coepidemic.
    AIDS. 2016;30:2715-2723.
    PubMed     Text format     Abstract available


    October 2016
  6. VAN DER WERF MJ, Kodmon C, Zucs P, Hollo V, et al
    Tuberculosis and HIV co-infection in Europe: looking at one reality from two angles.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    August 2016
  7. HIRA S, Piot P
    The counter effects of the ebola epidemic on control and treatment of HIV/AIDS, tuberculosis, and malaria in West Africa.
    AIDS. 2016.
    PubMed     Text format    


    June 2016
  8. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine and isoniazid for treatment of Mycobacterium tuberculosis infection in HIV-coinfected persons.
    AIDS. 2016;30:1607-15.
    PubMed     Text format     Abstract available


    March 2016
  9. STERLING TR, Scott NA, Miro JM, Calvet G, et al
    Three months of weekly rifapentine plus isoniazid for treatment of M. tuberculosis infection in HIV co-infected persons.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  10. SUMNER T, Houben RM, Rangaka MX, Maartens G, et al
    Post-Treatment Effect of Isoniazid Preventive Therapy on Tuberculosis Incidence in Hiv-Infected Individuals on Antiretroviral Therapy.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    January 2016
  11. MARAIS S, Meintjes G, Lesosky M, Wilkinson KA, et al
    Interleukin-17 mediated differences in the pathogenesis of HIV-1-associated tuberculous and cryptococcal meningitis.
    AIDS. 2016;30:395-404.
    PubMed     Text format     Abstract available


  12. KARO B, Krause G, Hollo V, van der Werf MJ, et al
    The impact of HIV infection on treatment outcome of tuberculosis: analysis of surveillance data from nine European countries, 2010-2012.
    AIDS. 2016.
    PubMed     Text format     Abstract available


  13. BOON SD, Matteelli A, Ford N, Getahun H, et al
    Continuous isoniazid for the treatment of latent tuberculosis infection in people living with HIV: a systematic review and meta-analysis.
    AIDS. 2016.
    PubMed     Text format     Abstract available


    November 2015
  14. BACHMANN MO, Timmerman V, Fairall LR
    Effect of antiretroviral treatment on the risk of tuberculosis during South Africa's programme expansion.
    AIDS. 2015;29:2261-8.
    PubMed     Text format     Abstract available


    September 2015
  15. YOTEBIENG M, Edmonds A, Lelo P, Wenzi LK, et al
    High completion of isoniazid preventive therapy among HIV-infected children and adults in Kinshasa, Democratic Republic of Congo.
    AIDS. 2015;29:2055-7.
    PubMed     Text format     Abstract available


    August 2015
  16. GUPTA RK, Lucas SB, Fielding KL, Lawn SD, et al
    Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis.
    AIDS. 2015.
    PubMed     Text format     Abstract available


    July 2015
  17. JOSEPH JP, Jerome G, Lambert W, Almazor P, et al
    Going beyond the vertical: leveraging a national HIV quality improvement programme to address other health priorities in Haiti.
    AIDS. 2015;29 Suppl 2:S165-73.
    PubMed     Text format     Abstract available


    June 2015
  18. GUPTA RK, Brown AE, Zenner D, Rice B, et al
    CD4+ cell count responses to antiretroviral therapy are not impaired in HIV-infected individuals with tuberculosis co-infection.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  19. LIU E, Makubi A, Drain P, Spiegelman D, et al
    Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    AIDS. 2015.
    PubMed     Text format     Abstract available


  20. RICHAUD C, Ghosn J, Amazzough K, Poiree S, et al
    Anti-tumor necrosis factor monoclonal antibody for steroid-dependent TB-IRIS in AIDS.
    AIDS. 2015;29:1117-9.
    PubMed     Text format    


    December 2014
  21. HARIDAS V, Pean P, Jasenosky LD, Madec Y, et al
    TB-IRIS and remodelling of the T-cell compartment in highly immunosuppressed HIV+ patients with TB: the CAPRI-T (ANRS-12614) study.
    AIDS. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: